Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 370 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ensysce Biosciences Inc | ENSC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0065 | -0.66% | 0.9721 | 08:33:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.9786 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 7 | 370 | - | 0.76495 - 18.36 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:38:59 | 1 | $ 0.9787 | USD |
Ensysce Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 42.19M | 3.15M | - | 2.52M | -25.09M | -7.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ensysce Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENSC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.79 | 1.49 | 0.79 | 1.11 | 926,821 | 0.1821 | 23.05% |
| 1 Month | 0.8827 | 1.49 | 0.76495 | 1.07 | 302,385 | 0.0894 | 10.13% |
| 3 Months | 1.80 | 1.87 | 0.76495 | 1.25 | 165,945 | -0.8279 | -45.99% |
| 6 Months | 2.34 | 2.64 | 0.76495 | 1.89 | 207,572 | -1.37 | -58.46% |
| 1 Year | 13.08 | 18.36 | 0.76495 | 7.53 | 931,088 | -12.11 | -92.57% |
| 3 Years | 3,825.60 | 4,108.80 | 0.76495 | 551.22 | 1,828,357 | -3,824.63 | -99.97% |
| 5 Years | 3,825.60 | 4,108.80 | 0.76495 | 551.22 | 1,828,357 | -3,824.63 | -99.97% |
Ensysce Biosciences Description
| Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. |
